ClinicalTrials.gg
Drug

Remestemcel-l clinical trials

Also written Prochymal®.

studies test it
16
open now
1
in phase 3
8
first study started
2005

How each study uses remestemcel-l is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the remestemcel-l studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
18 Dec 2024 · ryoncil · BLA 125706 (FDA, Purple Book)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Remestemcel-L
9
Adult Human Mesenchymal Stem Cells
3

Brand

Prochymal®
9

Studies by the year they started

16 studies that test it; most in 2008 (3)

Studies that test remestemcel-l, by start year
YearStudies
20052
20062
20071
20083
20091
20101
20152
20203
20261

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
8
Phase 3
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 13 · Other 3

Mesoblast, Inc. (12) · The Cleveland Clinic (2) · Mesoblast, Ltd. (1) · Icahn School of Medicine at Mount Sinai (1)

Studies

Open first, then newest update. How each study uses remestemcel-l is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 16

Codes

What other systems call remestemcel-l · ClinicalTrials.gg INT001463

  • MeSH (NLM) C000711674remestemcel-lConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) H57D26Z9YKREMESTEMCEL-LConfirmed FDA, NLM
  • NCI Thesaurus C67082Remestemcel-LOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.